I. Ancuta

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Ewa Orlewska, I. Ancuta, Branimir Anić et al. · Medical Science Monitor · 2011 · 73 citations · Full text

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Cem Gabay, Myriam Riek, Merete Lund Hetland et al. · Annals of the Rheumatic Diseases · 2015 · 70 citations · Full text

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Katerina Chatzidionysiou, Elisabeth Lie, E L Nasonov et al. · Arthritis Research & Therapy · 2016 · 48 citations · Full text

Prevalence and Characteristics of Psoriasis in Romania—First Study in Overall Population

Alin Codruț Nicolescu, Ștefana Bucur, Călin Giurcăneanu et al. · Journal of Personalized Medicine · 2021 · 40 citations · Full text